Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adagio Medical Holdings (ADGM) Depreciation and Depletion (2023 - 2026)

Adagio Medical Holdings (ADGM) reported Depreciation and Depletion of $200000.0 for Q1 2026, down 33.33% year-over-year from $300000.0 in Q1 2025, and little changed on a QoQ basis from $200000.0 in Q4 2025.

Adagio Medical Holdings (ADGM) has 4 years of Depreciation and Depletion data on file, last reported at $200000.0 in Q1 2026.

  • Quarterly Depreciation and Depletion fell 33.33% year-over-year to $200000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (changed 0.0% YoY) and the FY2025 annual result came in at $900000.0, up 28.57% from the prior year.
  • Depreciation and Depletion was little changed at $200000.0 in Q1 2026 per ADGM's latest filing, from $200000.0 in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $500000.0 in Q3 2025 and bottomed at $100000.0 in Q3 2023.
  • The 4-year median for Depreciation and Depletion is $200000.0 (2024), against an average of $240000.0.
  • Peak annual rise in Depreciation and Depletion reached 150.0% in 2025, while the deepest fall reached 33.33% in 2025.
  • Tracing ADGM's Depreciation and Depletion over 4 years: stood at $100000.0 in 2023, then surged by 100.0% to $200000.0 in 2024, then changed by 0.0% to $200000.0 in 2025, then changed by 0.0% to $200000.0 in 2026.
  • Per Business Quant, the three latest ADGM Depreciation and Depletion figures stand at $200000.0 (Q1 2026), $200000.0 (Q4 2025), and $500000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation and Depletion (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 381.00 Mn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 120.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 308.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 29.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 78.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Adagio Medical Holdings 16.86 Mn 3.95 Mn - 200,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 200,000.00
Mar 31, 2026 200,000.00
Dec 31, 2025 200,000.00
Dec 31, 2025 200,000.00
Sep 30, 2025 500,000.00
Sep 30, 2025 500,000.00
Jun 30, 2025 200,000.00
Jun 30, 2025 200,000.00
Mar 31, 2025 300,000.00
Mar 31, 2025 300,000.00
Sep 30, 2024 200,000.00
Sep 30, 2024 200,000.00
Jun 30, 2024 300,000.00
Jun 30, 2024 300,000.00
Mar 31, 2024 300,000.00
Mar 31, 2024 300,000.00
Dec 31, 2023 100,000.00
Dec 31, 2023 100,000.00
Sep 30, 2023 100,000.00
Sep 30, 2023 100,000.00